Related Experiment Video
Updated: Sep 2, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Factors associated with seizure severity among children with epilepsy in Northern Nigeria
Idris A Adedeji1, Adamu S Adamu1, Faruk M Bashir1
1Department of Paediatrics, Abubakar Tafawa Balewa University, Bauchi, Nigeria.
Insights
Neurological co-morbidities in children with epilepsy are linked to increased seizure severity. Identifying these comorbidities can help predict outcomes and guide treatment plans for pediatric epilepsy.
Area of Science:
- Pediatric Neurology
- Epilepsy Research
- Clinical Epidemiology
Background:
- Epilepsy is a common neurological disorder in children.
- Seizure severity can be influenced by various factors, including comorbidities.
- Understanding these influences is crucial for effective management.
Purpose of the Study:
- To investigate the association between socio-demographic and clinical variables and seizure severity in children with epilepsy.
- To identify predictors of seizure severity in a pediatric population.
Main Methods:
- A cross-sectional study was conducted with sixty children and adolescents diagnosed with epilepsy.
- Data on socio-demographics and neurological comorbidities were collected.
- Seizure severity was assessed using the National Hospital Seizure Severity Score (SSS).
Main Results:
- The mean Seizure Severity Score (SSS) was 12.22 ± 4.29.
- The presence of neurological comorbidities was significantly associated with higher SSS (p=0.019).
- Neurological comorbidities predicted an increase in SSS by 2.67 units.
Conclusions:
- Neurological comorbidities are significant predictors of increased seizure severity in children with epilepsy.
- This finding can aid in prognostication and treatment planning for pediatric epilepsy cases.
- Further research into managing comorbidities in epilepsy is warranted.
Objective:
To describe how seizure severity in children with epilepsy may be affected by certain socio-demographic and clinical variables.
Design:
A cross-sectional study.
Setting:
At the Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria.
Participants:
Sixty children and adolescents who were being followed up for seizure disorder at the child neurology clinic.
Intervention:
Information on socio-demographic characteristics was obtained with a questionnaire, details of neurological co-morbidities were extracted from the participants' records, and seizure severity was assessed with the National Hospital Seizure Severity Score 3 tool.
Main Outcome Measure:
Chi-square test was used to establish the relationship between categorical variables, while the Independent t-test was used in describing the differences between means. Simple linear regression was calculated to assess the predictability of seizure severity.
Result:
The median age was ten years (IQR = 6-13 years), with a male dominance (1.5:1). The Seizure Severity Score (SSS) ranged between 3 and 24 units, with a mean of 12.22 ± 4.29 units. The only characteristic that had a significant association with SSS on bivariate analysis was the "presence of co-morbidities" (p=0.019). A simple linear regression revealed that the presence of a neurological co-morbidity predicted an increase in the SSS by 2.67 units. [R2 = 0.091, F (1, 58)= 5.837, p = 0.019. β = 2.67, t= 2.42, p= 0.019.].
Conclusion:
This study shows that neurological co-morbidities predict worsening seizure severity. This knowledge may influence prognostication and the charting of a treatment trajectory.
Funding:
No external funding.
More Related Videos
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

